Toxicokinetics of kava

Advances in Pharmacological Sciences

Volumn 2011, Issue , 2011, Pages

  Ramzan, Iqbal ^a   Rowe, Anthony ^a   Zhang, Lillian Yuan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOCHROME P450 2D6; DEBRISOQUINE; DESMETHOXYYANGONIN; DIHYDROKAWAIN; DIHYDROMETHYSTICIN; FLAVOKAVAIN B; GAMMA GLUTAMYLTRANSFERASE; KAVA; KAVA EXTRACT; KAVALACTONE; KAWAIN; LACTONE; METHYSTICIN; PIPERMETHYSTINE; PLACEBO; PYRAN DERIVATIVE; UNCLASSIFIED DRUG; YANGONIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANXIETY DISORDER; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG EXCRETION; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HERB DRUG INTERACTION; HUMAN; HYDROXYLATION; INFLAMMATION; INSOMNIA; KUPFFER CELL; LD 50; LIVER PROTECTION; LIVER TOXICITY; META ANALYSIS (TOPIC); NAUSEA; NONHUMAN; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PARKINSONISM; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN DISEASE; SKIN MANIFESTATION; TOXICOKINETICS; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION; WITHDRAWAL SYNDROME;

EID: 79959274467     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2011/326724     Document Type: Review

References (54)

1. Whitton P. A., Lau A., Salisbury A., Whitehouse J., Evans C. S., Kava lactones and the kava-kava controversy Phytochemistry 2003 64 3 673 679 (Pubitemid 37176400)
2. Fu P. P., Xia Q., Guo L., Yu H., Chan P. C., Toxicity of kava kava Journal of Environmental Science and Health, Part C 2008 26 1 89 112 (Pubitemid 351347047)
3. Teschke R., Sarris J., Lebot V., Kava hepatotoxicity solution: a six-point plan for new kava standardization Phytomedicine 2011 18 2-3 96 103
4. Dinh L. D., Simmen U., Bueter K. B., Bueter B., Lundstrom K., Schaffner W., Interaction of various Piper methysticum cultivars with CNS receptors in vitro Planta Medica 2001 67 4 306 311 (Pubitemid 32588563)
5. Clayton N. P., Yoshizawa K., Kissling G. E., Burka L. T., Chan P. C., Nyska A., Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract Experimental and Toxicologic Pathology 2007 58 4 223 236 (Pubitemid 44873076)
6. Zou L., Henderson G. L., Harkey M. R., Sakai Y., Li A., Effects of kava (kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes Phytomedicine 2004 11 4 285 294 (Pubitemid 38657457)
7. Mulholland P. J., Prendergast M. A., Post-insult exposure to () kavain potentiates N -methyl-D-aspartate toxicity in the developing hippocampus Brain Research 2002 945 1 106 113 (Pubitemid 34756582)
8. Tang J., Dunlop R. A., Rowe A., Rodgers K. J., Ramzan I., Kavalactones yangonin and methysticin induce apoptosis in human hepatocytes (HepG2) in vitro Phytotherapy Research 2011 25 3 417 423
9. Tarbah F., Barguil Y., Weinmann W., Death after consumption of kava beverage in combination with alcohol and cannabis GTFCh (Society of Toxicological and Forensic Chemistry) Symposium 2003 Mosbach, Germany
10. Dragull K., Yoshida W. Y., Tang C. S., Piperidine alkaloids from Piper methysticum Phytochemistry 2003 63 2 193 198 (Pubitemid 36560138)
11. Nerurkar P. V., Dragull K., Tang C. S., In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones Toxicological Sciences 2004 79 1 106 111 (Pubitemid 38660254)
12. Lim S. T. S., Dragull K., Tang C. S., Bittenbender H. C., Efird J. T., Nerurkar P. V., Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats Toxicological Sciences 2007 97 1 214 221 (Pubitemid 47072170)
13. Lechtenberg M., Quandt B., Schmidt M., Nahrstedt A., Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products? Pharmazie 2008 63 1 71 74 (Pubitemid 351187597)
14. Jhoo J. W., Freeman J. P., Heinze T. M., Moody J. D., Schnackenberg L. K., Beger R. D., Dragull K., Tang C. S., Ang C. Y. W., In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum) Journal of Agricultural and Food Chemistry 2006 54 8 3157 3162
15. Xuan T. D., Fukuta M., Wei A. C., Elzaawely A. A., Khanh T. D., Tawata S., Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots Journal of Natural Medicines 2008 62 2 188 194 (Pubitemid 351365814)
16. Zhou P., Gross S., Liu J.-H., Yu B.-Y., Feng L.-L., Nolta J., Sharma V., Piwnica-Worms D., Qiu S. X., Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF- B and MAPK signaling pathways FASEB Journal 2010 24 12 4722 4732
17. Vanuatu Legislation: Kava Act. 2002, http://www.paclii.org/databases. html#VU
18. Lebot V., Merlin M., Lindstrom L., Kava, the Pacific Elixir 1997 Rochester, Vt, USA Yale University Press
19. Teschke R., Genthner A., Wolff A., Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures Journal of Ethnopharmacology 2009 123 3 378 384
20. Pittler M. H., Ernst E., Kava extract for treating anxiety Cochrane Database of Systematic Reviews 2003 1
21. Witte S., Loew D., Gaus W., Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders Phytotherapy Research 2005 19 3 183 188 (Pubitemid 40827638)
22. Connor K. M., Davidson J. R. T., Churchill L. E., Witte S., Loew D., Gaus W., Adverse-effect profile of kava CNS Spectrums 2001 6 10 848 853 (Pubitemid 34027308)
23. Clouatre D. L., Kava kava: examining new reports of toxicity Toxicology Letters 2004 150 1 85 96 (Pubitemid 38447238)
24. Teschke R., Schwarzenboeck A., Hennermann K. H., Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases European Journal of Gastroenterology Hepatology 2008 20 12 1182 1193
25. Teschke R., Schwarzenboeck A., Akinci A., Kava hepatotoxicity: a European view New Zealand Medical Journal 2008 121 1283 90 98
26. Norton S. A., Ruze P., Kava dermopathy Journal of the American Academy of Dermatology 1994 31 1 89 97 (Pubitemid 24198170)
27. Ulbricht C., Basch E., Boon H., Ernst E., Hammerness P., Sollars D., Tsourounis C., Woods J., Bent S., Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration Expert Opinion on Drug Safety 2005 4 4 779 794 (Pubitemid 40946072)
28. Ramzan I., Tran H. V., Singh Y. N., Chemistry of kava and kavalactones Kava: From Ethnology to Pharmacology (Medicinal and Aromatic PlantsIndustrial Profile) 2004 Boca Raton, Fla, USA CRC Press 76 103
29. Barnes J., Anderson L. A., Phillipson J. D., Herbal Medicines. 2007, http://www.medicinescomplete.com/mc/herbals/2008/1000734502.htm#hrb1000756090
30. Duffield A. M., Jamieson D. D., Lidgard R. O., Duffield P. H., Bourne D. J., Identification of some human urinary metabolites of the intoxicating beverage kava Journal of Chromatography A 1989 475 273 281 (Pubitemid 19193596)
31. Kppel C., Tenczer J., Mass spectral characterization of urinary metabolites of D,L-kawan Journal of Chromatography B 1991 562 1-2 207 211
32. Rasmussen A. K., Scheline R. R., Solheim E., Hansel R., Metabolism of some kava pyrones in the rat Xenobiotica 1979 9 1 1 16 (Pubitemid 9093507)
33. Tarbah F., Mahler H., Kardel B., Weinmann W., Hafner D., Daldrup T., Kinetics of kavain and its metabolites after oral application Journal of Chromatography B 2003 789 1 115 130 (Pubitemid 36513793)
34. Zou L., Harkey M. R., Henderson G. L., Synthesis, in vitro reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion Planta Medica 2005 71 2 142 146 (Pubitemid 40363557)
35. Johnson B. M., Qiu S. X., Zhang S., Zhang F., Burdette J. E., Yu L., Bolton J. L., Van Breemen R. B., Identification of novel electrophilic metabolites of Piper methysticum Forst. (kava) Chemical Research in Toxicology 2003 16 6 733 740 (Pubitemid 36736604)
36. Mathews J. M., Etheridge A. S., Valentine J. L., Black S. R., Coleman D. P., Patel P., So J., Burka L. T., Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro Drug Metabolism and Disposition 2005 33 10 1555 1563 (Pubitemid 41324005)
37. Russmann S., Barguil Y., Cabalion P., Kritsanida M., Duhet D., Lauterburg B. H., Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia European Journal of Gastroenterology Hepatology 2003 15 9 1033 1036 (Pubitemid 37094305)
38. Russmann S., Lauterburg B. H., Helbling A., Kava hepatotoxicity Annals of Internal Medicine 2001 135 1 68 69
39. Ingelman-Sundberg M., Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity Pharmacogenomics Journal 2005 5 1 6 13 (Pubitemid 40220611)
40. Escher M., Desmeules J., Giostra E., Mentha G., Hepatitis associated with kava, a herbal remedy for anxiety British Medical Journal 2001 322 7279 139 (Pubitemid 32116192)
41. Fu S., Korkmaz E., Braet F., Ngo Q., Ramzan I., Influence of kavain on hepatic ultrastructure World Journal of Gastroenterology 2008 14 4 541 546 (Pubitemid 351320819)
42. Clough A. R., Jacups S. P., Wang Z., Burns C. B., Bailie R. S., Cairney S. J., Collie A., Guyula T., McDonald S. P., Currie B. J., Health effects of kava use in an eastern Arnhem Land Aboriginal community Internal Medicine Journal 2003 33 8 336 340 (Pubitemid 37082791)
43. Clough A. R., Bailie R. S., Currie B., Liver function test abnormalities in users of aqueous kava extracts Journal of Toxicology. Clinical Toxicology 2003 41 6 821 829 (Pubitemid 37499010)
44. Brown A. C., Onopa J., Holck P., Kaufusi P., Kabasawa D., Craig W. J., Dragull K., Levine A. M., Baker J. D., Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii Clinical Toxicology 2007 45 5 549 556 (Pubitemid 46763668)
45. Zollner G., Trauner M., Mechanisms of cholestasis Clinics in Liver Disease 2008 12 1 1 26 (Pubitemid 351163143)
46. Roberts R. A., Ganey P. E., Ju C., Kamendulis L. M., Rusyn I., Klaunig J. E., Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis Toxicological Sciences 2007 96 1 2 15 (Pubitemid 46323203)
47. Kolios G., Valatas V., Kouroumalis E., Role of Kupffer cells in the pathogenesis of liver disease World Journal of Gastroenterology 2006 12 46 7413 7420 (Pubitemid 46017736)
48. Wheeler M. D., Kono H., Yin M., Nakagami M., Uesugi T., Arteel G. E., Gbele E., Rusyn I., Yamashina S., Froh M., Adachi Y., Iimuro Y., Bradford B. U., Smutney O. M., Connor H. D., Mason R. P., Goyert S. M., Peters J. M., Gonzalez F. J., Samulski R. J., Thurman R. G., The role of Kupffer cell oxidant production in early ethanol-induced liver disease Free Radical Biology and Medicine 2001 31 12 1544 1549 (Pubitemid 34026339)
49. Li J. Y., Gu X., Zhang W. H., Jia S., Zhou Y., GdCl 3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats Hepatobiliary and Pancreatic Diseases International 2009 8 5 518 523
50. Henrich D., Lehnert M., Herzog C., Niederlaender S., Relja B., Conzelmann L., Marzi I., Differential effects of GdCl 3 or MDP treatment on rat liver microcirculation and gene expression in the hepatic non-parenchymal cell fraction in LPS shock Microcirculation 2008 15 5 427 439 (Pubitemid 351927731)
51. Sturm E., Havinga R., Baller J. F. W., Wolters H., Van Rooijen N., Kamps J. A. A. M., Verkade H. J., Karpen S. J., Kuipers F., Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats Journal of Hepatology 2005 42 1 102 109 (Pubitemid 40038907)
52. Du S. S., Qiang M., Zeng Z. C., Ke AI. W., Ji Y., Zhang Z. Y., Zeng H. Y., Liu Z., Inactivation of Kupffer cells by gadolinium chloride protects murine liver from radiation-induced apoptosis International Journal of Radiation Oncology Biology Physics 2010 76 4 1225 1234
53. Huang W., Metlakunta A., Dedousis N., Zhang P., Sipula I., Dube J. J., Scott D. K., O'Doherty R. M., Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 2010 59 2 347 357
54. Neafsey P., Ginsberg G., Hattis D., Sonawane B., Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): population distribution of CYP2D6 activity Journal of Toxicology and Environmental Health Part B 2009 12 5-6 334 361